In the BioHarmony Drug Report Database

"Preview" Icon

Dalteparin

Fragmin (dalteparin sodium) is an oligosaccharide pharmaceutical. Dalteparin sodium was first approved as Fragmin on 1994-12-22. It is used to treat myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, and thrombophlebitis amongst others in the USA. The pharmaceutical is active against antithrombin-III.

 

Trade Name

 

Fragmin
 

Common Name

 

dalteparin sodium
 

ChEMBL ID

 

CHEMBL1201460
 

Indication

 

myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, thrombophlebitis, unstable angina
 

Drug Class

 

Heparin derivatives and low molecular weight (or depolymerized) heparins

Image (chem structure or protein)

Dalteparin structure rendering